Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillancePatient experience in the treatment of metastatic castration-resistant prostate cancer: state of the scienceMetabolic syndrome, inflammation and lower urinary tract symptoms: possible translational linksPET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challengesA review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patientsEffect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled studyWhat's hot in the prostate?Delayed life-threatening hemorrhage after transrectal prostate needle biopsyImmunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissuesalpha(1)-Blocker therapy in the nineties: focus on the diseaseDistress due to unwanted side-effects of prostate cancer treatment is related to impaired well-being (quality of life)Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixturesAssociation of male circumcision with risk of prostate cancer: a meta-analysisBrn-3a neuronal transcription factor functional expression in human prostate cancerThe diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devices.Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity.Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review.Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer.Quality of life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer.Multimodality radiotherapy and androgen ablation in the treatment of clinically localized prostate cancer: early results in high risk patients.Transformation dependent signalling pathways leading to transcriptional induction of vascular endothelial growth factor in prostate cancer.PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure.Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.Clinical ease of using doxazosin in BPH patients with and without hypertension.Role of denosumab in prostate cancer.Intermittent versus continuous hormone deprivation in metastatic prostate cancer: preliminary data from an ongoing European study.Insulin-like Growth Factor (IGF) Network and Prostate Pathologies.Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer.Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode laser system: results of an evolving technology.Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension.p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.Impact of treatment of BPH on sexuality.Gene delivery into prostate cancer cells by holmium laser application.Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trialsProstate specific antigen measurements after minimally invasive surgery of the prostate in men with benign prostatic hypertrophy.Quantitative expression profile of PSGR in prostate cancer.Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.Evaluation of ideal irrigation fluid in 'Greenlight' photoselective vapourization of the prostate.
P1433
Q24627957-6A7F382E-DFE7-499F-BA2F-FAC9E82F20A8Q26772883-5FC191EB-5082-4B76-BDD0-DB568A2C3BBBQ26782663-86C08AE0-2B78-4DE8-809C-322218AF349AQ28067404-717BDF42-B18A-4CAD-A290-B78C703C5EC6Q28076622-AFCF6BF4-27EC-44ED-924D-47B767C0A75EQ28182845-EB0CDCB5-4C62-4F68-A725-FB0F3B7AB6BCQ28194500-33105E9D-1A51-437C-B182-679006182BB6Q28196449-C0047B65-8827-4BF1-B835-40055B178CEFQ28206587-C8CD4DEC-BFDF-4C0E-A66C-F92548F65900Q28218791-A9D26D41-18A4-4CD6-87D7-9BCCB230321EQ28218795-3589E4F3-63C9-4AF5-9D86-450E212AE088Q28218810-90974BBD-28AC-464A-AF7C-B90C29C8BB8BQ28265596-4529639A-757C-4C48-A948-DFB2BC6AED40Q28280920-DACEFFD5-FB54-4CEB-BEC2-5EC75F6E79AAQ30205705-560A6D58-DB88-41F0-90CE-58995D747376Q30234092-CE2ED64F-9816-4BC5-A993-9BA0A03FCBE8Q30234760-AE688DA1-3D86-4391-89F9-4C6232B4F198Q30300480-A711C176-1D1C-4902-BB30-D55264CC95ACQ30310351-3F651D96-C47B-4F54-B56E-BE4AD0807D2EQ30310352-49E2B600-1C24-44CB-B341-3B35E6F9F09FQ30310355-01AAB7FF-AA83-448A-99E7-EC213161F361Q30365461-D8C9321D-F6AF-45E7-8531-6A120BBFE80AQ30385364-DE30D287-D42C-4CC3-80A8-10DA5FC86125Q30435930-355C326D-B82B-480C-B6DB-28B210B783F9Q30455154-78233960-483C-4C18-BAC2-2222AA595980Q30757471-F4F97FC4-E2E3-42D0-9EFC-6D0CE80B89EFQ30757478-9CA2DC5F-16AA-4373-902D-59271C1386E5Q30792328-D42AD9AD-3904-4756-9ED7-7BF818E819B2Q30877519-016D7CB3-D2ED-4EAC-A7E5-81CF1D111036Q30882787-CE17557D-867A-4CF0-90D5-DB5AB74FB83EQ31031743-47F66411-4144-4526-99AC-BFB084786814Q31122270-96783D9E-62F1-43EF-88C0-EF196D67F216Q31146315-D77BA6E3-C484-4FC9-AE61-0E05547C8FB0Q31146413-A8A1925C-3C63-44C6-B6B8-55D4635A10E5Q31152383-5C662132-6E34-4BE5-94E2-81AD88F44CF2Q33185519-84C8DD56-ACCB-406C-AC87-392784DCFFF6Q33225361-42AA6994-2C10-46F6-901E-B5B02E8F582BQ33227693-60D84B0A-7EB9-42C7-A23C-6C12681C20F5Q33247276-0A79DE74-C125-45F4-B6AD-B524CD48757CQ33260023-FE06ACBD-7D74-49E6-95E2-4C53ABC93AC4
P1433
description
Medical journal
@en
Medical journal
@en-gb
Medizinische Fachzeitschrift
@de
Revue médicale
@fr
periodiek van uitgeverij Nature Publishing Group
@nl
revista científica
@es
rivista scientifica
@it
वैज्ञानिक पत्रिका
@hi
name
Prostate Cancer and Prostatic Diseases
@da
Prostate Cancer and Prostatic Diseases
@de
Prostate Cancer and Prostatic Diseases
@en
Prostate Cancer and Prostatic Diseases
@en-ca
Prostate Cancer and Prostatic Diseases
@en-gb
Prostate Cancer and Prostatic Diseases
@es
Prostate Cancer and Prostatic Diseases
@fi
Prostate Cancer and Prostatic Diseases
@fr
Prostate Cancer and Prostatic Diseases
@it
Prostate Cancer and Prostatic Diseases
@nb
type
label
Prostate Cancer and Prostatic Diseases
@da
Prostate Cancer and Prostatic Diseases
@de
Prostate Cancer and Prostatic Diseases
@en
Prostate Cancer and Prostatic Diseases
@en-ca
Prostate Cancer and Prostatic Diseases
@en-gb
Prostate Cancer and Prostatic Diseases
@es
Prostate Cancer and Prostatic Diseases
@fi
Prostate Cancer and Prostatic Diseases
@fr
Prostate Cancer and Prostatic Diseases
@it
Prostate Cancer and Prostatic Diseases
@nb
altLabel
Prostate Cancer Prostatic Dis.
@de
Prostate Cancer Prostatic Dis.
@en
Prostate Cancer Prostatic Dis.
@en-gb
Prostate Cancer Prostatic Dis.
@fr
prefLabel
Prostate Cancer and Prostatic Diseases
@da
Prostate Cancer and Prostatic Diseases
@de
Prostate Cancer and Prostatic Diseases
@en
Prostate Cancer and Prostatic Diseases
@en-ca
Prostate Cancer and Prostatic Diseases
@en-gb
Prostate Cancer and Prostatic Diseases
@es
Prostate Cancer and Prostatic Diseases
@fi
Prostate Cancer and Prostatic Diseases
@fr
Prostate Cancer and Prostatic Diseases
@it
Prostate Cancer and Prostatic Diseases
@nb
P3181
P1055
P1058
P1156
P1277
P1476
Prostate Cancer and Prostatic Diseases
@en
P236
P3181
P407
P571
1997-01-01T00:00:00Z